{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:49:04Z","timestamp":1794361744315,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12325-025-03251-2","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T03:54:17Z","timestamp":1749182057000},"page":"3762-3773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sustained Metabolic Improvements with Low-Dose Metformin Combined with Oral Contraceptives in Female Adolescents with PCOS: A Single-Center Retrospective Cohort Study"],"prefix":"10.1007","volume":"42","author":[{"given":"Salvatore Giovanni","family":"Vitale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Di Michele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Tassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Succu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Angioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Fulghesu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"3251_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41\u20137.","journal-title":"Hum Reprod"},{"key":"3251_CR2","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","volume":"3","author":"SF Witchel","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019;3:1545\u201373.","journal-title":"J Endocr Soc"},{"key":"3251_CR3","doi-asserted-by":"publisher","DOI":"10.1159\/000542393","author":"AM Fulghesu","year":"2024","unstructured":"Fulghesu AM, Di Michele S, Zangaris I, Cordella M, Pittui E, Scalise G, et al. Clinical and ultrasound features of normocyclic non-hyperandrogenic adolescents in early gynecological life. Gynecol Obstet Investig. 2024. https:\/\/doi.org\/10.1159\/000542393.","journal-title":"Gynecol Obstet Investig."},{"key":"3251_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3390\/biomedicines13020453","volume":"13","author":"S Di Michele","year":"2025","unstructured":"Di Michele S, Fulghesu AM, Pittui E, Cordella M, Sicilia G, Mandurino G, et al. Ultrasound assessment in polycystic ovary syndrome diagnosis: from origins to future perspectives\u2014a comprehensive review. Biomedicines. 2025;13:453.","journal-title":"Biomedicines"},{"key":"3251_CR5","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1007\/s43032-021-00765-2","volume":"29","author":"JV Kolhe","year":"2022","unstructured":"Kolhe JV, Chhipa AS, Butani S, Chavda V, Patel SS. PCOS and depression: common links and potential targets. Reprod Sci. 2022;29:3106\u201323.","journal-title":"Reprod Sci"},{"key":"3251_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2005.10.007","volume":"185","author":"AJ Cussons","year":"2006","unstructured":"Cussons AJ, Stuckey BGA, Watts GF. Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives. Atherosclerosis. 2006;185:227\u201339.","journal-title":"Atherosclerosis"},{"key":"3251_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/09637486.2021.1950129","volume":"73","author":"SG Vitale","year":"2022","unstructured":"Vitale SG, Fiore M, La Rosa VL, Rapisarda AMC, Mazza G, Paratore M, et al. Liposomal ferric pyrophosphate and ascorbic acid supplementation in pregnant women with iron deficiency anaemia: haematochemical, obstetric, neonatal and psychological outcomes in a prospective observational study. Int J Food Sci Nutr. 2022;73:221\u20139.","journal-title":"Int J Food Sci Nutr"},{"key":"3251_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3390\/metabo11070437","volume":"11","author":"AM Fulghesu","year":"2021","unstructured":"Fulghesu AM, Piras C, Dess\u00ec A, Succu C, Atzori L, Pintus R, et al. Urinary metabolites reveal hyperinsulinemia and insulin resistance in polycystic ovarian syndrome (PCOS). Metabolites. 2021;11:437.","journal-title":"Metabolites"},{"key":"3251_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.23736\/S2724-606X.21.04758-4","volume":"74","author":"MN D\u2019Alterio","year":"2022","unstructured":"D\u2019Alterio MN, Sigilli M, Succu AG, Ghisu V, Lagan\u00e0 AS, Sorrentino F, et al. Pregnancy outcomes in women with polycystic ovarian syndrome. Minerva Obstet Gynecol. 2022;74:45\u201359.","journal-title":"Minerva Obstet Gynecol"},{"key":"3251_CR10","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/biomedicines10081816","volume":"10","author":"SG Vitale","year":"2022","unstructured":"Vitale SG, Fulghesu AM, Miku\u0161 M, Watrowski R, D\u2019Alterio MN, Lin L-T, et al. The translational role of miRNA in polycystic ovary syndrome: from bench to bedside-a systematic literature review. Biomedicines. 2022;10:1816.","journal-title":"Biomedicines"},{"key":"3251_CR11","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.fertnstert.2014.12.109","volume":"103","author":"AM Fulghesu","year":"2015","unstructured":"Fulghesu AM, Manca R, Loi S, Fruzzetti F. Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome. Fertil Steril. 2015;103:808\u201314.","journal-title":"Fertil Steril"},{"key":"3251_CR12","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s12325-018-0723-z","volume":"35","author":"H Salman","year":"2018","unstructured":"Salman H, Shah M, Ali A, Aziz A, Vitale SG. Assessment of relationship of serum neurokinin-B level in the pathophysiology of pre-eclampsia: a case-control study. Adv Ther. 2018;35:1114\u201321.","journal-title":"Adv Ther"},{"key":"3251_CR13","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jadohealth.2009.10.008","volume":"46","author":"A Fulghesu","year":"2010","unstructured":"Fulghesu A, Magnini R, Portoghese E, Angioni S, Minerba L, Melis GB. Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome. J Adolesc Health. 2010;46:474\u201381.","journal-title":"J Adolesc Health"},{"key":"3251_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35: 100937.","journal-title":"Mol Metab"},{"key":"3251_CR15","doi-asserted-by":"publisher","first-page":"204201882093830","DOI":"10.1177\/2042018820938305","volume":"11","author":"MA Abdalla","year":"2020","unstructured":"Abdalla MA, Deshmukh H, Atkin S, Sathyapalan T. A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2020;11:2042018820938305.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"3251_CR16","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/09637486.2020.1852191","volume":"72","author":"SG Vitale","year":"2021","unstructured":"Vitale SG, Corrado F, Caruso S, Di Benedetto A, Giunta L, Cianci A, et al. Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes - a randomized and open-label, placebo-controlled clinical trial. Int J Food Sci Nutr. 2021;72:670\u20139.","journal-title":"Int J Food Sci Nutr"},{"key":"3251_CR17","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3390\/jcm13061722","volume":"13","author":"S Di Michele","year":"2024","unstructured":"Di Michele S, Bramante S, Angioni S, Bernassola M, De Vita T, Iaccarino DA, et al. Superficial peritoneal endometriosis vaporization using a CO2 laser: a long-term single-center experience. J Clin Med. 2024;13:1722.","journal-title":"J Clin Med"},{"key":"3251_CR18","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.3390\/jcm13195677","volume":"13","author":"S Di Michele","year":"2024","unstructured":"Di Michele S, Bramante S, Rosati M. A systematic review of ureteral reimplantation techniques in endometriosis: laparoscopic versus robotic-assisted approach. J Clin Med. 2024;13:5677.","journal-title":"J Clin Med"},{"key":"3251_CR19","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/humrep\/dead156","volume":"38","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2023;38:1655\u201379.","journal-title":"Hum Reprod"},{"key":"3251_CR20","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1111\/aogs.14802","volume":"103","author":"F de Zegher","year":"2024","unstructured":"de Zegher F, Ib\u00e1\u00f1ez L. Leader vs follower in the tango of polycystic ovary syndrome: Insulin resistance vs androgen excess. Acta Obstet Gynecol Scand. 2024;103:1680\u20131.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3251_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie Y, Liu Y, Long S, Mo Z. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214\u201321.","journal-title":"Clin Chim Acta"},{"key":"3251_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00404-024-07897-1","volume":"311","author":"V Unfer","year":"2025","unstructured":"Unfer V, Lepore E, Forte G, Hern\u00e1ndez Mar\u00edn I, Wdowiak A, Pkhaladze L. Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis. Arch Gynecol Obstet. 2025;311:25\u201332.","journal-title":"Arch Gynecol Obstet"},{"key":"3251_CR23","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3390\/diagnostics12081931","volume":"12","author":"AS Pe\u00f1a","year":"2022","unstructured":"Pe\u00f1a AS, Codner E, Witchel S. Criteria for diagnosis of polycystic ovary syndrome during adolescence: literature review. Diagnostics (Basel). 2022;12:1931.","journal-title":"Diagnostics (Basel)"},{"issue":"201","key":"3251_CR24","first-page":"e1","volume":"203","author":"E Carmina","year":"2010","unstructured":"Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol. 2010;203(201):e1-5.","journal-title":"Am J Obstet Gynecol"},{"key":"3251_CR25","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"3251_CR26","first-page":"299","volume":"7","author":"C Cremoncini","year":"1976","unstructured":"Cremoncini C, Vignati E, Libroia A. Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol. Acta Eur Fertil. 1976;7:299\u2013314.","journal-title":"Acta Eur Fertil"},{"key":"3251_CR27","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2337\/diab.28.12.1039","volume":"28","author":"National Diabetes Data Group","year":"1979","unstructured":"National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039\u201357.","journal-title":"Diabetes"},{"key":"3251_CR28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.fertnstert.2006.01.024","volume":"86","author":"AM Fulghesu","year":"2006","unstructured":"Fulghesu AM, Angioni S, Portoghese E, Milano F, Batetta B, Paoletti AM, et al. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome. Fertil Steril. 2006;86:398\u2013404.","journal-title":"Fertil Steril"},{"key":"3251_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"3251_CR30","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1093\/humrep\/des262","volume":"27","author":"AM Fulghesu","year":"2012","unstructured":"Fulghesu AM, Romualdi D, Di Florio C, Sanna S, Tagliaferri V, Gambineri A, et al. Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study. Hum Reprod. 2012;27:3057\u201366.","journal-title":"Hum Reprod"},{"key":"3251_CR31","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1055\/a-1018-9606","volume":"51","author":"D Ali","year":"2019","unstructured":"Ali D, Shah M, Ali A, Malik MO, Rehman F, Badshah H, et al. Treatment with metformin and combination of metformin plus pioglitazone on serum levels of IL-6 and IL-8 in polycystic ovary syndrome: a randomized clinical trial. Horm Metab Res. 2019;51:714\u201322.","journal-title":"Horm Metab Res"},{"key":"3251_CR32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMcp1514916","volume":"375","author":"CR McCartney","year":"2016","unstructured":"McCartney CR, Marshall JC. Clinical practice. Polycystic ovary syndrome. N Engl J Med. 2016;375:54\u201364.","journal-title":"N Engl J Med"},{"key":"3251_CR33","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1007\/s00125-017-4306-3","volume":"60","author":"S Sam","year":"2017","unstructured":"Sam S, Ehrmann DA. Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome. Diabetologia. 2017;60:1656\u201361.","journal-title":"Diabetologia"},{"key":"3251_CR34","first-page":"139","volume":"85","author":"P Moghetti","year":"2000","unstructured":"Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab. 2000;85:139\u201346.","journal-title":"J Clin Endocrinol Metab"},{"key":"3251_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.741764","volume":"12","author":"H Ding","year":"2021","unstructured":"Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, et al. Resistance to the insulin and elevated level of androgen: a major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12: 741764.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3251_CR36","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1210\/jc.2007-0441","volume":"92","author":"S Palomba","year":"2007","unstructured":"Palomba S, Falbo A, Russo T, Manguso F, Tolino A, Zullo F, et al. Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92:3128\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"3251_CR37","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1080\/03007995.2021.1955667","volume":"37","author":"U Hostalek","year":"2021","unstructured":"Hostalek U, Campbell I. Metformin for diabetes prevention: update of the evidence base. Curr Med Res Opin. 2021;37:1705\u201317.","journal-title":"Curr Med Res Opin"},{"key":"3251_CR38","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/antiox10050708","volume":"10","author":"A Deledda","year":"2021","unstructured":"Deledda A, Annunziata G, Tenore GC, Palmas V, Manzin A, Velluzzi F. Diet-derived antioxidants and their role in inflammation, obesity and gut microbiota modulation. Antioxidants (Basel). 2021;10:708.","journal-title":"Antioxidants (Basel)"},{"key":"3251_CR39","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.2147\/DMSO.S328694","volume":"14","author":"F Jevtovic","year":"2021","unstructured":"Jevtovic F. Combination of metformin and exercise in management of metabolic abnormalities observed in type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2021;14:4043\u201357.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"3251_CR40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/jdi.13709","volume":"13","author":"T Kimura","year":"2022","unstructured":"Kimura T, Kaneto H. Metformin induces insulin secretion by preserving pancreatic aquaporin 7 expression in type 2 diabetes mellitus. J Diabetes Investig. 2022;13:227\u20139.","journal-title":"J Diabetes Investig"},{"key":"3251_CR41","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1093\/humrep\/dem202","volume":"22","author":"AM Fulghesu","year":"2007","unstructured":"Fulghesu AM, Angioni S, Frau E, Belosi C, Apa R, Mioni R, et al. Ultrasound in polycystic ovary syndrome\u2014the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study. Hum Reprod. 2007;22:2501\u20138.","journal-title":"Hum Reprod"},{"key":"3251_CR42","first-page":"90","volume":"36","author":"M Farimani Sanoee","year":"2011","unstructured":"Farimani Sanoee M, Neghab N, Rabiee S, Amiri I. Metformin therapy decreases hyperandrogenism and ovarian volume in women with polycystic ovary syndrome. Iran J Med Sci. 2011;36:90\u20135.","journal-title":"Iran J Med Sci"},{"key":"3251_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12958-021-00765-6","volume":"19","author":"M Ohara","year":"2021","unstructured":"Ohara M, Yoshida-Komiya H, Ono-Okutsu M, Yamaguchi-Ito A, Takahashi T, Fujimori K. Metformin reduces androgen receptor and upregulates homeobox A10 expression in uterine endometrium in women with polycystic ovary syndrome. Reprod Biol Endocrinol. 2021;19:77.","journal-title":"Reprod Biol Endocrinol"},{"key":"3251_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cbi.2016.06.008","volume":"259","author":"AE S\u00f8rensen","year":"2016","unstructured":"S\u00f8rensen AE, Udesen PB, Wissing ML, Englund ALM, Dalgaard LT. MicroRNAs related to androgen metabolism and polycystic ovary syndrome. Chem Biol Interact. 2016;259:8\u201316.","journal-title":"Chem Biol Interact"},{"key":"3251_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archpedi.160.3.241","volume":"160","author":"T Bridger","year":"2006","unstructured":"Bridger T, MacDonald S, Baltzer F, Rodd C. Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome. Arch Pediatr Adolesc Med. 2006;160:241\u20136.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"3251_CR46","first-page":"CD005552","volume":"8","author":"E Fraison","year":"2020","unstructured":"Fraison E, Kostova E, Moran LJ, Bilal S, Ee CC, Venetis C, et al. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database Syst Rev. 2020;8:CD005552.","journal-title":"Cochrane Database Syst Rev"},{"key":"3251_CR47","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.tem.2023.08.005","volume":"34","author":"SH Myers","year":"2023","unstructured":"Myers SH, Russo M, Dinicola S, Forte G, Unfer V. Questioning PCOS phenotypes for reclassification and tailored therapy. Trends Endocrinol Metab. 2023;34:694\u2013703.","journal-title":"Trends Endocrinol Metab"},{"key":"3251_CR48","doi-asserted-by":"publisher","first-page":"E204","DOI":"10.1210\/jc.2010-0145","volume":"95","author":"A Gambineri","year":"2010","unstructured":"Gambineri A, Tomassoni F, Gasparini DI, Di Rocco A, Mantovani V, Pagotto U, et al. Organic cation transporter 1 polymorphisms predict the metabolic response to metformin in women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 2010;95:E204-208.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03251-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-025-03251-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-025-03251-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:06:06Z","timestamp":1757181966000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-025-03251-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3251"],"URL":"https:\/\/doi.org\/10.1007\/s12325-025-03251-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Salvatore Giovanni Vitale is an Editorial Board Member of Advances in Therapy and was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Stefano\u202fDi\u202fMichele, Alice\u202fTassi, Claudia\u202fSuccu, Stefano\u202fAngioni, and Anna\u202fMaria\u202fFulghesu have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study adhered to the Declaration of Helsinki. Informed consent was obtained from parents for each subject. Institutional review board approval was secured from the Sardinia Regional Territorial Ethics Committee (prot. no. 41, 27-5-2024 All. 2.10). Regarding informed consent, in our university gynecology outpatient clinic, it is standard practice to have patients sign a general consent form, which states that their data may be used for retrospective studies and potentially published in the future. Specifically, for adolescent and therefore underage patients, such as those included in this retrospective study, parental consent is obtained for both participation in the study and the potential publication of the data within our database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}